These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17896397)

  • 21. Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Tanaka M; Yoshikawa D; Hayashi M; Yasuda Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ J; 2012; 76(7):1609-15. PubMed ID: 22484980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of drug-eluting and bare-metal stents for stable coronary artery disease.
    Horst B; Rihal CS; Holmes DR; Bresnahan JF; Prasad A; Gau G; Lennon R; Lerman A
    JACC Cardiovasc Interv; 2009 Apr; 2(4):321-8. PubMed ID: 19463444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and mid-term clinical outcomes with the CATANIA coronary stent system vs. bare metal stents in patients with coronary artery disease.
    Capodanno D; La Manna A; Di Salvo ME; Sanfilippo A; Corcos T; Tamburino C
    Cardiovasc Revasc Med; 2009; 10(4):216-20. PubMed ID: 19815167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort.
    Vlaar PJ; Rihal CS; Singh M; Lennon R; Ting HH; Bresnahan JF; Holmes DR
    Catheter Cardiovasc Interv; 2008 May; 71(6):764-9. PubMed ID: 18412074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
    Spaulding C; Teiger E; Commeau P; Varenne O; Bramucci E; Slama M; Beatt K; Tirouvanziam A; Polonski L; Stella PR; Clugston R; Fajadet J; de Boisgelin X; Bode C; Carrié D; Erglis A; Merkely B; Hosten S; Cebrian A; Wang P; Stoll HP; Henry P
    JACC Cardiovasc Interv; 2011 Jan; 4(1):14-23. PubMed ID: 21251624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of percutaneous coronary intervention for chronic total occlusions.
    Mehran R; Claessen BE; Godino C; Dangas GD; Obunai K; Kanwal S; Carlino M; Henriques JP; Di Mario C; Kim YH; Park SJ; Stone GW; Leon MB; Moses JW; Colombo A;
    JACC Cardiovasc Interv; 2011 Sep; 4(9):952-61. PubMed ID: 21939934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.
    Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Clinical Outcomes of Fractional Flow Reserve-Guided Versus Routine Drug-Eluting Stent Implantation in Patients With Intermediate Coronary Stenosis: Five-Year Clinical Outcomes of DEFER-DES Trial.
    Park SH; Jeon KH; Lee JM; Nam CW; Doh JH; Lee BK; Rha SW; Yoo KD; Jung KT; Cho YS; Lee HY; Youn TJ; Chung WY; Koo BK
    Circ Cardiovasc Interv; 2015 Dec; 8(12):e002442. PubMed ID: 26643736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
    Hannan EL; Racz M; Walford G; Holmes DR; Jones RH; Sharma S; Katz S; King SB
    JACC Cardiovasc Interv; 2008 Apr; 1(2):129-35. PubMed ID: 19463290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical outcomes of drug-eluting stents vs bare-metal stents in Chinese patients.
    Ho HH; Pong V; Siu CW; Jim MH; Miu R; Yiu KH; Ko R; Tse HF; Kwok OH; Chow WH
    Clin Cardiol; 2010 Jun; 33(6):E22-9. PubMed ID: 20556818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.
    Li SJ; Ge Z; Kan J; Zhang JJ; Ye F; Kwan TW; Santoso T; Yang S; Sheiban I; Qian XS; Tian NL; Rab TS; Tao L; Chen SL
    JACC Cardiovasc Interv; 2017 May; 10(10):986-995. PubMed ID: 28456699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
    Tonino PA; De Bruyne B; Pijls NH; Siebert U; Ikeno F; van' t Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; Fearon WF;
    N Engl J Med; 2009 Jan; 360(3):213-24. PubMed ID: 19144937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry.
    Burzotta F; Trani C; Todaro D; Mazzari MA; Porto I; De Vita M; Brugaletta S; Coroleu SF; Niccoli G; Leone AM; Giammarinaro M; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):457-65. PubMed ID: 19229977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
    Wijnbergen I; Helmes H; Tijssen J; Brueren G; Peels K; van Dantzig JM; Van' t Veer M; Koolen JJ; Pijls NH; Michels R
    JACC Cardiovasc Interv; 2012 Mar; 5(3):313-22. PubMed ID: 22440498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary revascularization in patients with small-vessel disease.
    Puymirat E; Peace A; Mangiacapra F; Conte M; Ntarladimas Y; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
    Circ Cardiovasc Interv; 2012 Feb; 5(1):62-8. PubMed ID: 22319067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.